Sex hormones regulate tenofovir-diphosphate in female reproductive tract cells in culture

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Shen, Zheng ^a   Fahey, John V ^a   Bodwell, Jack E ^a   Rodriguez Garcia, Marta ^a   Kashuba, Angela D M ^b   Wira, Charles R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; ESTRADIOL; PROGESTERONE; TENOFOVIR; TENOFOVIR DIPHOSPHATE; UNCLASSIFIED DRUG; ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ORGANOPHOSPHATE;

ARTICLE; BIOACCUMULATION; CD4+ T LYMPHOCYTE; CELL COUNT; CELL CULTURE; CELL ISOLATION; CELL LEVEL; CONTROLLED STUDY; ENDOMETRIUM CELL; FEMALE; FEMALE GENITAL SYSTEM; FIBROBLAST; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MONOCYTE; UTERINE CERVIX; ADULT; AGED; ANALOGS AND DERIVATIVES; ANTIBODY SPECIFICITY; CYTOLOGY; DRUG EFFECTS; ENDOMETRIUM; EPITHELIUM CELL; METABOLISM; MIDDLE AGED; PRIMARY CELL CULTURE; SURGERY; TRANSPORT AT THE CELLULAR LEVEL;

ADENINE; ADULT; AGED; ANTI-HIV AGENTS; BIOLOGICAL TRANSPORT; CD4-POSITIVE T-LYMPHOCYTES; CERVIX UTERI; ENDOMETRIUM; EPITHELIAL CELLS; ESTRADIOL; FEMALE; FIBROBLASTS; HUMANS; MACROPHAGES; MIDDLE AGED; ORGAN SPECIFICITY; ORGANOPHOSPHATES; PRIMARY CELL CULTURE; PROGESTERONE;

EID: 84903555266     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100863     Document Type: Article

References (34)

1. UNAIDS (2013) UNAIDS report on the global AIDS.
2. CAC (2003) HIV/AIDS Surveillance Report.
3. Ghosh M, Rodriguez-Garcia M, Wira CR (2013) Immunobiology of genital tract trauma: endocrine regulation of HIV acquisition in women following sexual assault or genital tract mutilation. Am J Reprod Immunol 69 Suppl 1: 51-60.
4. (2012) HIV/AIDS.
5. Wira CR, Fahey JV (2008) A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 22: 1909-1917.
6. Hickey DK, Patel MV, Fahey JV, Wira CR (2011) Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol 88: 185-194.
7. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L (2005) Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 206: 306-335.
8. Heneine W, Kashuba A (2012) HIV Prevention by Oral Preexposure Prophylaxis. Cold Spring Harb Perspect Med 2: a007419.
9. Rohan LC, Moncla BJ, Kunjara Na Ayudhya RP, Cost M, Huang Y, et al. (2010) In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. PLoS One 5: e9310.
10. van der Straten A, Van Damme L, Haberer JE, Bangsberg DR (2012) Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS 26: F13-19.
11. Romano J, Kashuba A, Becker S, Cummins J, Turpin J, et al. (2013) Pharmacokinetics and Pharmacodynamics in HIV Prevention; Current Status and Future Directions: A Summary of the DAIDS and BMGF Sponsored Think Tank on Pharmacokinetics (PK)/Pharmacodynamics (PD) in HIV Prevention. AIDS Res Hum Retroviruses 29: 1418-1427.
12. Hendrix CW, Chen BA, Guddera V, Hoesley C, Justman J, et al. (2013) MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments. PLoS One 8: e55013.
13. Chen J, Flexner C, Liberman RG, Skipper PL, Louissaint NA, et al. (2012) Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing study. J Acquir Immune Defic Syndr 61: 593-599.
14. Anderson PL, Kiser JJ, Gardner EM, Rower JE, Meditz A, et al. (2011) Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. J Antimicrob Chemother 66: 240-250.
15. Fahey JV, Schaefer TM, Channon JY, Wira CR (2005) Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum Reprod 20: 1439-1446.
16. Fahey JV, Wira CR (2002) Effect of menstrual status on anti-bacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis 185: 1606-1613.
17. Meter RA, Wira CR, Fahey JV (2005) Secretion of monocyte chemotactic protein-1 by human uterine epithelium directs monocyte migration in culture. Fertil Steril 84: 191-201.
18. Koumas L, King AE, Critchley HO, Kelly RW, Phipps RP (2001) Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts. Am J Pathol 159: 925-935.
19. MacDonald EM, Savoy A, Gillgrass A, Fernandez S, Smieja M, et al. (2007) Susceptibility of human female primary genital epithelial cells to herpes simplex virus, type-2 and the effect of TLR3 ligand and sex hormones on infection. Biol Reprod 77: 1049-1059.
20. Shen Z, Fahey JV, Bodwell JE, Rodriguez-Garcia M, Rossoll RM, et al. (2013) Estradiol regulation of nucleotidases in female reproductive tract epithelial cells and fibroblasts. PLoS One 8: e69854.
21. Rodriguez-Garcia M, Biswas N, Patel MV, Barr FD, Crist SG, et al. (2013) Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIVinfection. PLoS One 8: e62069.
22. McNatty KP, Baird DT, Bolton A, Chambers P, Corker CS, et al. (1976) Concentration of oestrogens and androgens in human ovarian venous plasma and follicular fluid throughout the menstrual cycle. J Endocrinol 71: 77-85.
23. Patterson KB, Prince HA, Kraft E, Jenkins AJ, Shaheen NJ, et al. (2011) Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med 3: 112re114.
24. Givan AL, White HD, Stern JE, Colby E, Gosselin EJ, et al. (1997) Flow cytometric analysis of leukocytes in the human female reproductive tract: Comparison of Fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 38: 350-359.
25. Kashuba AD, Patterson KB, Dumond JB, Cohen MS (2012) Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet 379: 2409-2411.
26. Kohler JJ, Hosseini SH, Hoying-Brandt A, Green E, Johnson DM, et al. (2009) Tenofovir renal toxicity targets mitochondria of renal proximal tubules. Lab Invest 89: 513-519.
27. Kohler JJ, Hosseini SH (2011) Subcellular renal proximal tubular mitochondrial toxicity with tenofovir treatment. Methods Mol Biol 755: 267-277.
28. Abraham P, Ramamoorthy H, Isaac B (2013) Depletion of the cellular antioxidant system contributes to tenofovir disoproxil fumarate - induced mitochondrial damage and increased oxido-nitrosative stress in the kidney. J Biomed Sci 20: 61.
29. Wira CR, Fahey JV, Ghosh M, Patel MV, Hickey DK, et al. (2010) Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol 63: 544-565.
30. Coleman KD, Wright JA, Ghosh M, Wira CR, Fahey JV (2009) Estradiol modulation of hepatocyte growth factor by stromal fibroblasts in the female reproductive tract. Fertil Steril 92: 1107-1109.
31. Patel MV, Fahey JV, Rossoll RM, Wira CR (2013) Innate immunity in the vagina (part I): estradiol inhibits HBD2 and elafin secretion by human vaginal epithelial cells. Am J Reprod Immunol 69: 463-474.
32. Murphy AJ, Guyre PM, Wira CR, Pioli PA (2009) Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages. PLoS One 4: e5539.
33. Hunsucker SA, Mitchell BS, Spychala J (2005) The 5′-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol Ther 107: 1-30.
34. Coleman J, Chaturvedula A, Heendrix C, Team M-P (2012) Method of hormonal contraception is associated with lower tenofovir concentration in healthy women (MTN-001): implications for pre-exposure prophylaxis. XIX International AIDS Conference AIDS 2012. Washington, DC.